Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
297 Leser
Artikel bewerten:
(1)

Hydrow Announces $55M in Series D Funding

Finanznachrichten News

The connected fitness challenger brand to lead innovation in the category

BOSTON, March 17, 2022 /PRNewswire/ -- Hydrow, the leading at-home connected rower that brings the on-water experience of rowing straight to your home, today announced it has raised approximately $55 million in Series D funding. This latest round of funding was led by Constitution Capital with continued support from L Catterton and RX3 Ventures and additional participation from Liberty Street, Activant Capital and Sandbridge Capital.

The new capital will enable continued investment in product innovation, facilitate global expansion, accelerate brand awareness and scale operations needed to meet the rapidly-growing consumer demand.

"As more and more people embrace a hybrid approach to fitness, we continue to see extraordinary adoption, and our top priority is ensuring we can keep meeting that demand," said Bruce Smith, CEO and Founder of Hydrow. "This latest round of funding will not only allow us to do that, but will give us the opportunity to further invest in our product offering and drive innovation, so we can continue to deliver a best-in-class experience for our members."

"We were drawn to Hydrow's unparalleled workout experience, and remain impressed by its distinct positioning in connected fitness, as well as the exceptional quality of the management team leading the organization. We are thrilled to partner with a company with such a strong growth trajectory," said Vil Ramos, Partner, Constitution Capital.

Over this past year, Hydrow has experienced continued momentum with revenue growing more than 3x from 2020 to 2021. Further, the Hydrow community is growing rapidly, with over 200,000 users. Hydrow has also expanded its offering for members, releasing workouts from exciting new locations across the US and Europe, and all-new workout formats, including coastal rowing. The company also bolstered its all-star Athlete roster this winter with the addition of Singapore's first Olympic rower, Aisyah Rafaee.

"We continue to have strong conviction in Hydrow's growth prospects as consumers are increasingly drawn to rowing as an efficient and effective workout to fuel their busy lives," said Michael Farello, a Managing Partner in L Catterton's Growth Fund. "Even as gyms and studios reopen their doors, we remain confident that connected fitness is here to stay and differentiated concepts such as Hydrow are well-positioned for the future."

Hydrow's commitment to the expansion of the sport of rowing will continue to fuel further innovation as the company strives to meet consumers where they are on their physical and mental wellness journeys. Hydrow currently offers nearly 4,000 live and on-demand workouts led by world-class athletes, including Olympians and Paralympians, that transport users to breathtaking waterways around the world, with locales including London, Lucerne, Miami, Los Angeles, Boston and more.

For more information and updates on Hydrow, visit http://hydrow.com.

About Hydrow
Hydrow is the leading at-home connected rower that leverages innovative technology to bring the on-water, outdoor experience of rowing to the home. Engineered by elite rowing experts, Hydrow recreates the feeling of rowing directly on the water via an algorithm-based, patented electromagnetic and computer-controlled drag mechanism. World-class athletes lead users through challenging rows that engage 86% of the body's major muscle groups, twice that of cycling or running, while the rower's On the Mat workouts, from yoga, to Pilates and strength training, complement users' rowing regimen. With the ability to harness the visual, auditory and emotional components of rowing, the connected fitness rower delivers a best-in-class, full-body workout.

About Constitution Capital
Constitution Capital, with offices in Boston and New York, is a leading alternative asset manager focused on private equity and private credit investments. The firm is a disciplined, value-oriented investor with a demonstrated track record of consistently generating risk-adjusted returns. The firm is led by an experienced, cohesive team of investment professionals with significant experience investing in partnerships, direct equity, and opportunistic credit. For more information about Constitution Capital, please see www.concp.com.

About L Catterton
With more than $30 billion of equity capital across its fund strategies and 17 offices around the world, L Catterton is the largest global consumer-focused private equity firm. Leveraging deep category insight, operational excellence, and a broad strategic network of relationships, L Catterton's team of nearly 200 investment and operating professionals support management teams around the world in building strong, category-leading brands. Since 1989, the firm has made approximately 250 investments in consumer businesses. For more information about L Catterton, please visit lcatterton.com.

Press Contact:
Michael Braun
michael@hydrow.com

Logo - https://mma.prnewswire.com/media/1630745/Hydrow_Logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.